← Leaderboards
Gervasio A Lamas
Mount Sinai Medical Center (Miami Beach)
$61,796,196
Attributed
$61,796,196
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9M · FY2007–21$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$61,796,196 · 6
By mechanism
U01$32,123,224 · 3
UH3$17,668,619 · 1
R01$11,540,027 · 1
UG3$464,326 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Chelation Therapy”
- Russell E Ware · Duke University$33,922,841
- Katherine W Ferrara · Stanford University$9,354,377
- Daniel B Mark · Duke University$8,316,321
- Kevin J Anstrom · Univ Of North Carolina Chapel Hill$8,316,321
- Elliott P Vichinsky · University Of California San Francisco$7,083,586
- Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med$6,852,311
Research focus
Chelation TherapyMyocardial InfarctionPlacebosBaseInfusion ProceduresChelationOralEventEnrollmentGrantNational Center For Complementary And Alternative MedicineEdetic AcidCardiovascular SystemMultivitaminDesignDiabetes MellitusHospitalizationCardiovascular DiseasesCreatinineClinical ResearchDiabetic PatientCoronaryCostRequest For Applications
Grant awards (24)
Metals in the Trial to Assess Chelation Therapy 2 (TACT2M)$1,171,824
R01 · FY2021 · AT · contact PI
Trial to Assess Chelation Therapy 2- TACT2 CCC$1,153,749
UH3 · FY2021 · AT · contact PI
Trial to Assess Chelation Therapy 2- TACT2 CCC$915,502
UH3 · FY2021 · AT · contact PI
Metals in the Trial to Assess Chelation Therapy 2 (TACT2M)$227,501
R01 · FY2021 · AT · contact PI
Trial to Assess Chelation Therapy 2- TACT2 CCC$1,144,023
UH3 · FY2020 · AT · contact PI
Metals in the Trial to Assess Chelation Therapy 2 (TACT2M)$1,000,000
R01 · FY2020 · AT · contact PI
Metals in the Trial to Assess Chelation Therapy 2 (TACT2M)$3,840,976
R01 · FY2018 · AT · contact PI
Trial to Assess Chelation Therapy 2- TACT2 CCC$3,715,954
UH3 · FY2018 · AT · contact PI
Trial to Assess Chelation Therapy 2- TACT2 CCC$3,585,989
UH3 · FY2017 · AT · contact PI
Metals in the Trial to Assess Chelation Therapy 2 (TACT2M)$3,353,944
R01 · FY2017 · AT · contact PI
Trial to Assess Chelation Therapy 2- TACT2 CCC$2,027,925
UH3 · FY2017 · AT · contact PI
Trial to Assess Chelation Therapy 2- TACT2 CCC$5,125,477
UH3 · FY2016 · AT · contact PI
Metals in the Trial to Assess Chelation Therapy 2 (TACT2M)$1,945,782
R01 · FY2016 · AT · contact PI
Trial to Assess Chelation Therapy 2- TACT2 CCC$64,326
UG3 · FY2016 · AT · contact PI
Trial to Assess Chelation Therapy 2- TACT2 CCC$400,000
UG3 · FY2015 · AT · contact PI
Trial to Assess Chelation Therapy (TACT)$1,816,603
U01 · FY2012 · HL · contact PI
Trial to Assess Chelation Therapy (TACT)$4,151,803
U01 · FY2009 · HL · contact PI
Trial to Assess Chelation Therapy (TACT)$2,494,247
U01 · FY2008 · HL · contact PI
Trial to Assess Chelation Therapy (TACT)$929,729
U01 · FY2008 · HL · contact PI
Trial to Assess Chelation Therapy (TACT)$4,086,877
U01 · FY2007 · HL · contact PI
Trial to Assess Chelation Therapy (TACT)$4,283,621
U01 · FY2004 · AT
Trial to Assess Chelation Therapy (TACT)$7,659,673
U01 · FY2003 · AT
Trial to Assess Chelation Therapy (TACT)$6,207,279
U01 · FY2002 · AT
MODE SELECTION TRIAL IN SINUS NODE DYSFUNCTION (MOST)$493,392
U01 · FY2000 · HL